Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Pitango
AddedFeb 13, 2024
UpdatedJun 28, 2026
Pitango

Pitango

Operating

Pitango, an Israeli VC fund, partners with innovative startups via three funds: First, Growth, and HealthTech.

Location
Herzliya, Tel Aviv District, IL
Founded
1993
Firm
Compare
Portfolio
Fundraising
Employees
News
Website

Pitango, established in 1993 and headquartered in Herzliya, Israel, is the country's largest venture capital fund with over $2.8 billion under management. The firm invests through three dedicated funds: Pitango First (early-stage investments), Pitango Growth, and Pitango HealthTech. They typically engage in various investment rounds, including Seed, Series A, B, C, D, and E, supporting startups from stealth mode to mature companies.

Notable portfolio companies include AppsFlyer, Via, and Tomorrow.io. Key partners include co-founders Rami Kalish and Chemi Peres. Pitango's investment philosophy focuses on partnering with visionary entrepreneurs and providing them with strategic guidance and resources to scale their businesses. The firm offers unique value-add services such as tailored newsletters and sector-specific insights, enhancing their portfolio companies' growth and market positioning.

Pitango - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments112
Current Portfolio Count43
Total Portfolio Exits6

Top Investment Stages

Series B26 (26.8%)
Series A24 (24.7%)
Series C23 (23.7%)
Series Unknown13 (13.4%)
Series D11 (11.3%)

Stage Mix

Series B 27%Series A 25%Series C 24%Series Unknown 13%Series D 11%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Connie Health logo

Connie Health

Variantyx logo

Variantyx

Surge Therapeutics logo

Surge Therapeutics

Localize logo

Localize

Tomorrow.io logo

Tomorrow.io

Vertos Medical logo

Vertos Medical

Volumez logo

Volumez

Zorro logo

Zorro

OpenEyes logo

OpenEyes

Via logo

Via

Homethrive logo

Homethrive

D-ID logo

D-ID

Visby Medical logo

Visby Medical

Sayata logo

Sayata

Lumigo logo

Lumigo

Aquant logo

Aquant

Totango logo

Totango

Tulip Interfaces logo

Tulip Interfaces

Tailor Brands logo

Tailor Brands

Kaminario logo

Kaminario

Venn logo

Venn

Mend logo

Mend

Medisafe logo

Medisafe

ImmuneID logo

ImmuneID

TScan Therapeutics logo

TScan Therapeutics

Pitango - Similar Investment Firms

Cerca Partners logo

Cerca Partners

cerca-partners.com

Takwin Labs logo

Takwin Labs

takwinventures.com

Piton Capital logo

Piton Capital

pitoncap.com

Terralab Ventures logo

Terralab Ventures

Terra Venture Partners logo

Terra Venture Partners

terravp.com

Pico Venture Partners logo

Pico Venture Partners

pico.partners

Partech logo

Partech

Tal Ventures logo

Tal Ventures

tal-ventures.com

Pontifax logo

Pontifax

pontifax.com

Viola Partners logo

Viola Partners

viola-group.com

Pentech Ventures logo

Pentech Ventures

Sequoia Capital Israel logo

Sequoia Capital Israel

P1 Ventures logo

P1 Ventures

p1.ventures

Intango Ventures logo

Intango Ventures

F2 Capital logo

F2 Capital

f2vc.com

Pitango - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
NAICS
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end